Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

European journal of endocrinology - 1 Feb 2011

Falhammar Henrik, Filipsson Nyström Helena, Wedell Anna, Thorén Marja

Abstract excerpt

OBJECTIVE: Lifelong glucocorticoid therapy in patients with congenital adrenal hyperplasia (CAH) or the disease per se may result in increased cardiovascular risk. We therefore investigated cardiovascular and metabolic risk profiles in adult CAH males. SUBJECTS AND METHODS: We compared CAH males...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Hyperplasia, Congenital
Share to Blood Glucose
Share to Body Composition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Height

Share to Cardiovascular Diseases

Share to Lipids

Share to Steroid 21-Hydroxylase

Source

Identifiers

PMID: 21098686
DOI: 10.1530/EJE-10-0877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21098686-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.PMID 21098686Read ↗

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.Semantic proximity Read ↗

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.Semantic proximity Read ↗

[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].Semantic proximity Read ↗

Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.Semantic proximity Read ↗

Congenital adrenal hyperplasias.Semantic proximity Read ↗

Update on diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiencySemantic proximity Read ↗

The next 150 years of congenital adrenal hyperplasia.Semantic proximity Read ↗

Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood.Semantic proximity Read ↗

Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Semantic proximity Read ↗

Intima media thickness of common carotids and abdominal aorta in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in relation to their genotypes.Semantic proximity Read ↗

[Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].Semantic proximity Read ↗

Genotype and clinical outcomes in children with congenital adrenal hyperplasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.